Leadership Changes at Husky
The Canadian-headquartered supplier of injection molding machines, hot runners and tooling announced that Bradley Selleck will become CEO, replacing John Galt who will become chairman.
Husky Technologies, Bolton, Ontario, announced that longtime company CEO John Galt will transition to the role of chairman, and Husky COO Bradley Selleck will become CEO, effective Oct. 1.
Husky, a portfolio company of Platinum Equity, is a global provider of injection molding technologies, including molding machines, hot runners and tooling that primarily target the beverage, consumer good and medical device markets. Platinum completed the acquisition of Husky from Berkshire Partners and OMERS Private Equity in March 2018 for $3.85 billion.
Galt joined Husky in 1985 and was appointed CEO in 2005. Over that time, Husky says Galt has “played a pivotal role growing the ´óÏó´«Ã½ from its early days as a founder-led creative enterprise into a global industrial leader.”
Selleck joined Husky in 2022 with more than 25 years of leadership experience in operations, supply chain and quality as an executive for large-scale global industrial organizations, including L3Harris, United Technologies and Otis Elevator.

Bradley Selleck (pictured) will take over as CEO of Husky on Oct. 1, replacing John Galt, who will transition to chairman. Source: Husky Technologies
In his role as chairman, Husky says Galt will continue to serve as an advocate for advancing sustainability across the industry and be available to the leadership team to assist with customer and investor relations, as well as advanced product development.
“Leading Husky has been one of the greatest honors of my career,” Galt says. “Over the last 19 years as CEO, I have seen this company evolve into a global leader, driven by our relentless pursuit of innovation and our commitment to making a positive impact on the world.”
Earlier this year on July 11, Husky founder Robert Schad passed away at the age of 95. Schad founded Husky in 1953 as a tool-making company. When he sold the company in 2007, it had achieved sales of $1 billion with more than 3,300 employees in over 100 countries.
Related Content
-
A Systematic Approach to Process Development
The path to a no-baby-sitting injection molding process is paved with data and can be found by following certain steps.
-
Back to Basics on Mold Venting (Part 1)
Here’s what you need to know to improve the quality of your parts and to protect your molds.
-
What to Look for in High-Speed Automation for Pipette Production
Automation is a must-have for molders of pipettes. Make sure your supplier provides assurances of throughput and output, manpower utilization, floor space consumption and payback period.